{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:23:47Z","timestamp":1793258627955,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bcmd.2023.102801","type":"journal-article","created":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T17:43:54Z","timestamp":1699206234000},"page":"102801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Clonal hematopoiesis and acquired genetic abnormalities of the red cell: An historical review"],"prefix":"10.1016","volume":"104","author":[{"given":"Marshall A.","family":"Lichtman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2023.102801_bb0005","first-page":"77","article-title":"Acquired disorders of hemoglobin","volume":"8","author":"Bradley","year":"1973","journal-title":"Prog Hematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.1960.tb06230.x","article-title":"An unstable haemoglobin associated with some cases of leukaemia","volume":"6","author":"White","year":"1960","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0015","first-page":"225","article-title":"An unstable haemoglobin associated with myeloid leukaemia","volume":"10","author":"Mathur","year":"1962","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.bcmd.2023.102801_bb0020","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/1991297a0","article-title":"Occurrence of haemoglobin H in leukaemia","volume":"199","author":"Beaven","year":"1963","journal-title":"Nature."},{"key":"10.1016\/j.bcmd.2023.102801_bb0025","first-page":"92","article-title":"Acquired hemoglobin H disease associated with idiopathic myelofibrosis and hereditary adenosine deaminase deficiency","volume":"43","author":"Nakatsuji","year":"1980","journal-title":"Nihon Ketsueki Gakkai Zasshi."},{"key":"10.1016\/j.bcmd.2023.102801_bb0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0092-8674(77)90198-2","article-title":"Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay","volume":"12","author":"Deisseroth","year":"1977","journal-title":"Cell."},{"key":"10.1016\/j.bcmd.2023.102801_bb0035","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1073\/pnas.75.3.1456","article-title":"Chromosomal localization of human beta globin gene on human chromosome 11 in somatic cell hybrids","volume":"75","author":"Deisseroth","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2023.102801_bb0040","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.75.12.5950","article-title":"The duplicated human alpha globin genes lie close together in cellular DNA","volume":"75","author":"Orkin","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7663","key":"10.1016\/j.bcmd.2023.102801_bb0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0140-6736(70)92645-0","article-title":"Different types of alpha-thalassaemia and significance of haemoglobin Bart's in neonates","volume":"1","author":"Lehmann","year":"1970","journal-title":"Lancet."},{"issue":"5505","key":"10.1016\/j.bcmd.2023.102801_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/255255a0","article-title":"Deletion of alpha-globin genes in haemoglobin-H disease demonstrates multiple alpha-globin structural loci","volume":"255","author":"Kan","year":"1975","journal-title":"Nature."},{"issue":"5628","key":"10.1016\/j.bcmd.2023.102801_bb0055","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/269524a0","article-title":"Molecular basis for acquired haemoglobin H disease","volume":"269","author":"Old","year":"1977","journal-title":"Nature."},{"key":"10.1016\/j.bcmd.2023.102801_bb0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.1978.tb01049.x","article-title":"Acquired haemoglobin H disease in leukemia: pathophysiology and molecular basis","volume":"38","author":"Weatherall","year":"1978","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0002-9343(83)91189-0","article-title":"Clinical features and molecular analysis of acquired hemoglobin H disease","volume":"75","author":"Higgs","year":"1983","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcmd.2023.102801_bb0070","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.V73.5.1081.1081","article-title":"A review of the molecular genetics of the human alpha-globin gene cluster","volume":"73","author":"Higgs","year":"1989","journal-title":"Blood."},{"key":"10.1016\/j.bcmd.2023.102801_bb0075","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/jmg.28.11.738","article-title":"X linked alpha thalassaemia\/mental retardation: spectrum of clinical features in three related males","volume":"28","author":"Wilkie","year":"1991","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bcmd.2023.102801_bb0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jcp.44.2.134","article-title":"Globin chain synthesis in myelodysplastic syndromes","volume":"44","author":"Chalevelakis","year":"1991","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0092-8674(95)90287-2","article-title":"Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome)","volume":"80","author":"Gibbons","year":"1995","journal-title":"Cell."},{"key":"10.1016\/j.bcmd.2023.102801_bb0090","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng1213","article-title":"Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS)","author":"Gibbons","year":"2003","journal-title":"Nat. Genet."},{"issue":"103","key":"10.1016\/j.bcmd.2023.102801_bb0095","first-page":"2019","article-title":"Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome associated with alpha thalassemia (ATMDS)","volume":"15","author":"Gibbons","year":"2004","journal-title":"Blood."},{"issue":"103","key":"10.1016\/j.bcmd.2023.102801_bb0100","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2003-09-3360","article-title":"Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations","volume":"15","author":"Steensma","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.bcmd.2023.102801_bb0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood-2004-07-2792","article-title":"Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies","volume":"105","author":"Steensma","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.bcmd.2023.102801_bb0110","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2141.2007.06831.x","article-title":"Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders","volume":"139","author":"Steensma","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0115","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1182\/blood-2003-09-3222","article-title":"Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndrome","volume":"103","author":"Steensma","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.bcmd.2023.102801_bb0120","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/jcp.39.11.1233","article-title":"Increased alpha:non-alpha globin chain synthesis ratios in myelodysplastic syndromes and myeloid leukaemia","volume":"39","author":"Peters","year":"1986","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.bcmd.2023.102801_bb0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2141.1991.tb08017.x","article-title":"Acquired beta thalassaemia trait in MDS","volume":"79","author":"Hoyle","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0130","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1002\/ajh.24400","article-title":"Myelodysplastic syndrome associated with acquired beta thalassemia: \u201cBTMDS\u201d","volume":"91","author":"Brunner","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/03630268309038402","article-title":"Erythroleukemia manifesting delta beta-thalassemia","volume":"7","author":"Markham","year":"1983","journal-title":"Hemoglobin."},{"key":"10.1016\/j.bcmd.2023.102801_bb0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2141.1976.tb00952.x","article-title":"The patterns of fetal haemoglobin production in leukaemia","volume":"32","author":"Sheridan","year":"1976","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0145","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12185-023-03570-6","article-title":"Effect of haplotypes of functional SNPs related to expression of fetal hemoglobin (HbF) on clinical prognosis of hematological malignancies","volume":"117","author":"Sales","year":"2023","journal-title":"Int. J. Hematol."},{"issue":"5075","key":"10.1016\/j.bcmd.2023.102801_bb0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/213522b0","article-title":"Decrease in the concentration of haemoglobin A2 during erythroleukaemia","volume":"213","author":"Aksoy","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2023.102801_bb0155","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0009-8981(70)90077-X","article-title":"The A2 hemoglobin in hematological diseases","volume":"28","author":"Brabec","year":"1970","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bcmd.2023.102801_bb0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/phpp.12501","article-title":"Acquired erythropoietic protoporphyria: a systematic review of the literature","volume":"36","author":"Snast","year":"2020","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.bcmd.2023.102801_bb0165","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/jid.2011.5","article-title":"Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria","volume":"131","author":"Sarkany","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/phpp.12720","article-title":"Acquired erythropoietic uroporphyria secondary to myeloid malignancy: a case report and literature review","volume":"38","author":"Serra-Garc\u00eda","year":"2022","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.bcmd.2023.102801_bb0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jdcr.2022.11.034","article-title":"Acquired erythropoietic uroporphyria associated with clonal cytopenia of undetermined significance","volume":"32","author":"Swanson","year":"2022","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.bcmd.2023.102801_bb0180","first-page":"486","article-title":"Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report","volume":"179","author":"Podlipnik","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.bcmd.2023.102801_bb0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ajcp\/82.3.354","article-title":"Marked elliptocytosis and schistocytosis in hematopoietic dysplasia","volume":"82","author":"Hartz","year":"1984","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000206351","article-title":"Elliptocytosis preceding myelofibrosis in a patient with polycythemia vera","volume":"72","author":"Djaldetti","year":"1984","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2023.102778","article-title":"Acquired elliptocytosis in chronic myeloid neoplasms: An enigmatic relationship to acquired red cell membrane protein and genetic abnormalities","volume":"103","author":"Lichtman","year":"2023","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2023.102801_bb0200","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.1993.tb03183.x","article-title":"Abnormal erythrocyte band 4.1 protein in myelodysplastic syndrome with elliptocytosis","volume":"85","author":"Ideguchi","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.seminhematol.2004.01.003","article-title":"Hereditary elliptocytosis: spectrin and protein 4.1R","volume":"41","author":"Gallagher","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2006.03.005","article-title":"The molecular basis of hereditary red cell membrane disorders","volume":"21","author":"Delaunay","year":"2007","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2023.102801_bb0215","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/bjh.13778","article-title":"The human Kell blood group binds the erythroid 4.1R protein: new insights into the 4.1R-dependent red cell membrane complex","volume":"171","author":"Azouzi","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.bcmd.2023.102801_bb0220","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2012-06-432237","article-title":"Acquired elliptocytosis of myelodysplastic syndrome","volume":"121","author":"Knight","year":"2013","journal-title":"Blood."},{"issue":"2018","key":"10.1016\/j.bcmd.2023.102801_bb0225","first-page":"6819172","article-title":"Acquired Elliptocytosis as a manifestation of myelodysplastic syndrome associated with deletion of chromosome 20q","volume":"1","author":"Manthri","year":"2018","journal-title":"Case Rep Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102801_bb0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjh.15746","article-title":"Acquired elliptocytosis in a patient with a myelodysplastic syndrome associated with 20q deletion","volume":"185","author":"Quiroz-Cervantes","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102801_bb0235","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000517","article-title":"Reticulocytosis as a whistleblower: a rare case of acquired elliptocytosis in a myelodysplastic syndrome patient with trisomy 8","volume":"5","author":"Hage-Sleiman","year":"2021","journal-title":"Hemasphere."},{"key":"10.1016\/j.bcmd.2023.102801_bb0240","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0145-2126(93)90038-M","article-title":"De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?","volume":"17","author":"Wattel","year":"1993","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102801_bb0245","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00277-011-1286-0","article-title":"Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study","volume":"91","author":"Mullier","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0250","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ajcp\/106.5.680","article-title":"Hematologic disorders associated with deletion of chromosome 20q: a clinicopathologic study of 107 patients","volume":"106","author":"Kurtin","year":"1996","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0255","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1182\/blood-2016-03-703876","article-title":"Acquired elliptocytosis in the setting of a refractory anemia with excess blasts and del(20q)","volume":"127","author":"Boutault","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102801_bb0260","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1182\/blood.V106.11.4927.4927","article-title":"Marked Elliptocytosis in myelodysplastic syndromes (MDS) is associated to deletion of chromosome 20q","volume":"106","author":"Baweja","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102801_bb0265","first-page":"395","article-title":"Decreased deformability of red cells in refractory anemia and the abnormality of the membrane skeleton","volume":"31","author":"Maeda","year":"1994","journal-title":"Biorheology"},{"issue":"2","key":"10.1016\/j.bcmd.2023.102801_bb0270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-4608(96)00334-2","article-title":"Isochromosome 14q in refractory anemia","volume":"97","author":"Boavida","year":"1997","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102801_bb0275","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0165-4608(98)00135-6","article-title":"Elliptocytosis in myelodysplastic syndrome associated with translocation (1;5)(p10;q10) and deletion of 20q","volume":"108","author":"Ishida","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"issue":"1","key":"10.1016\/j.bcmd.2023.102801_bb0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.0141-9854.2003.00583.x","article-title":"Protein 4.1 deficiency and deletion of chromosome 20q are associated with acquired elliptocytosis in myelodysplastic syndrome","volume":"26","author":"Hur","year":"2004","journal-title":"Clin. Lab. Haematol."},{"issue":"4","key":"10.1016\/j.bcmd.2023.102801_bb0285","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajh.21088","article-title":"Association between myeloid malignancies and acquired deficit in protein 4.1R: a retrospective analysis of six patients","volume":"83","author":"Alanio-Br\u00e9chot","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0290","first-page":"3625946","article-title":"Acquired Elliptocytosis as a manifestation of myelodysplastic syndrome with ring Sideroblasts and multilineage dysplasia","volume":"2017","author":"Kjelland","year":"2017","journal-title":"Case Rep Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102801_bb0295","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V13.2.192.192","article-title":"The Di Guglielmo syndrome","volume":"13","author":"Dameshek","year":"1958","journal-title":"Blood."},{"key":"10.1016\/j.bcmd.2023.102801_bb0300","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1006\/bcmd.2000.0335","article-title":"Myelodysplasia or myeloneoplasia: thoughts on the nosology of clonal myeloid diseases","volume":"26","author":"Lichtman","year":"2000","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2023.102801_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2021.102618","article-title":"Red cell anarchy. Evidence of neoplastic dyserythropoiesis","volume":"92","author":"Lichtman","year":"2021","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2023.102801_bb0310","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1182\/blood-2014-12-617142","article-title":"High-density genomic analysis reveals basis of spherocytosis in myelodysplastic syndrome","volume":"125","author":"Fraiman","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.bcmd.2023.102801_bb0315","article-title":"Acquired spherocytosis in the setting of myelodysplasia","volume":"17","author":"Karlsson","year":"2022","journal-title":"Leuk Res Rep."},{"key":"10.1016\/j.bcmd.2023.102801_bb0320","doi-asserted-by":"crossref","first-page":"E285","DOI":"10.1002\/ajh.26593","article-title":"Acquired spherocytosis due to somatic ANK1 mutations as a manifestation of clonal hematopoiesis in elderly patients","volume":"97","author":"Mansour-Hendili","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0325","first-page":"1627","article-title":"An\u00e9mies r\u00e9fractaires, \u00e9tats pr\u00e9-leuc\u00e9miques et anomalies enzymatiques multiples [Refractive anemia, preleukemic states and multiple enzymatic anomalies]","volume":"266","author":"Dreyfus","year":"1968","journal-title":"C R Acad Hebd Seances Acad Sci D."},{"key":"10.1016\/j.bcmd.2023.102801_bb0330","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood.V41.6.857.857","article-title":"Dyserythropoiesis, refractory anemia, and \u201cpreleukemia:\u201d metabolic features of the erythrocytes","volume":"41","author":"Valentine","year":"1973","journal-title":"Blood."},{"key":"10.1016\/j.bcmd.2023.102801_bb0335","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000459004","article-title":"Acquired red cell pyruvate kinase deficiency in leukemias and related disorders","volume":"19","author":"Boivin","year":"1975","journal-title":"Enzyme."},{"key":"10.1016\/j.bcmd.2023.102801_bb0340","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2141.1975.tb00888.x","article-title":"Acquired erythroenzymopathies in blood disorders: study of 200 cases","volume":"31","author":"Boivin","year":"1975","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0345","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000207900","article-title":"Acquired pyruvate kinase deficiency with hemolysis in preleukemia","volume":"57","author":"Helmst\u00e4dter","year":"1977","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bcmd.2023.102801_bb0350","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archinte.1986.00360160237030","article-title":"Preleukemia manifested by hemolytic anemia with pyruvate-kinase deficiency","volume":"146","author":"Kornberg","year":"1986","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2023.102801_bb0355","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0009-8981(76)90088-7","article-title":"Mechanisms of the acquired erythrocyte enzyme deficiencies in blood diseases","volume":"71","author":"Kahn","year":"1976","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bcmd.2023.102801_bb0360","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1182\/blood.V48.5.653.653","article-title":"Causal mechanisms of multiple acquired red cell enzyme defects in a patient with acquired dyserythropoiesis","volume":"48","author":"Kahn","year":"1976","journal-title":"Blood."},{"key":"10.1016\/j.bcmd.2023.102801_bb0365","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1111\/bjh.18037","article-title":"Acquired glucose 6-phosphate dehydrogenase (G6PD) deficiency in a patient with chronic Myelomonocytic leukemia","volume":"197","author":"Naville","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.bcmd.2023.102801_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/bloodadvances.2022007504","article-title":"U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes","volume":"10","author":"Komrokji","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2023.102801_bb0375","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/183892a0","article-title":"Changes in the group a antigen in a case of leuk\u00e6mia","volume":"183","author":"Gold","year":"1959","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2023.102801_bb0380","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.1969.tb00404.x","article-title":"Anomalies of blood group antigens and erythrocyte enzymes in two types of chronic refractory anaemia","volume":"16","author":"Dreyfus","year":"1969","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.bcmd.2023.102801_bb0385","first-page":"311","article-title":"Serologische und karyologische Ver\u00e4nderungen bei Kranken mit Blutkrankheiten und b\u00f6sartigen Geschw\u00fclsten [serological and karyological changes in patients with blood diseases and malignant neoplasms]","volume":"92","author":"M\u00e1jsk\u00fd","year":"1969","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch."},{"key":"10.1016\/j.bcmd.2023.102801_bb0390","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0165-4608(92)90328-6","article-title":"Acute leukemia with t(1;3)(p36;q21), evolution to t(1;3)(p36;q21), t(14;17)(q32;q21), and loss of red cell a and Le(b) antigens","volume":"64","author":"Marsden","year":"1992","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.bcmd.2023.102801_bb0395","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1182\/blood.V97.11.3633","article-title":"Loss of red cell a, B, and H antigens is frequent in myeloid malignancies","volume":"97","author":"Bianco","year":"2001","journal-title":"Blood."},{"key":"10.1016\/j.bcmd.2023.102801_bb0400","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4238\/vol7-1gmr401","article-title":"ABO genotyping in leukemia patients reveals new ABO variant alleles","volume":"7","author":"Novaretti","year":"2008","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.bcmd.2023.102801_bb0405","first-page":"74","article-title":"Blood group change in acute myeloid leukemia","volume":"30","author":"Nambiar","year":"2017","journal-title":"Proc (Bayl Univ Med Cent)."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979623000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979623000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:37:16Z","timestamp":1761050236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979623000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":81,"alternative-id":["S1079979623000785"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2023.102801","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal hematopoiesis and acquired genetic abnormalities of the red cell: An historical review","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2023.102801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102801"}}